OncoC4 is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biologicals for cancer treatment.OncoC4 has a pipeline of first-in-class immunotherapy products that are moving through preclinical testing it was founded in 2000 on the scientific discoveries of our founders who have moved our lead product, CD24Fc, from a basic concept into clinical trials fo...
OncoC4 is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biologicals for cancer treatment.OncoC4 has a pipeline of first-in-class immunotherapy products that are moving through preclinical testing it was founded in 2000 on the scientific discoveries of our founders who have moved our lead product, CD24Fc, from a basic concept into clinical trials for multiple indications. As part of global effort to confront COVID-19, OncoImmune has also completed a Phase III clinical trial, SAC-COVID, which showed that CD24Fc significantly improved clinical recovery.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.